CEL SCI CORP — Investor Relations & Filings
CEL-SCI Corporation is a clinical-stage biotechnology company engaged in the research and development of immunotherapies for cancer, autoimmune, and infectious diseases. Its lead investigational therapy, Multikine (Leukocyte Interleukin, Injection), is a neoadjuvant treatment designed to stimulate a patient's immune system to fight cancer before standard treatments like surgery, radiation, and chemotherapy are administered. The company has completed a global pivotal Phase III clinical trial for Multikine in patients with advanced primary, previously untreated squamous cell carcinoma of the head and neck. The study demonstrated a significant 5-year overall survival benefit in a specific patient subgroup. CEL-SCI is also developing its LEAPS (Ligand Epitope Antigen Presentation System) technology platform for potential treatments of autoimmune and infectious diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-1/A - CEL SCI CORP (0000725363) (Filer) | 2026-05-01 | English | |
| S-1 - CEL SCI CORP (0000725363) (Filer) | 2026-04-17 | English | |
| 10-Q - CEL SCI CORP (0000725363) (Filer) | 2026-02-17 | English | |
| 4 Filing | 2026-01-26 | English | |
| 4 Filing | 2026-01-05 | English | |
| 4 Filing | 2026-01-05 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 39639190 | S-1/A - CEL SCI CORP (0000725363) (Filer) | 2026-05-01 | English | ||
| 34662842 | S-1 - CEL SCI CORP (0000725363) (Filer) | 2026-04-17 | English | ||
| 32880286 | 10-Q - CEL SCI CORP (0000725363) (Filer) | 2026-02-17 | English | ||
| 18269065 | 4 Filing | 2026-01-26 | English | ||
| 18269090 | 4 Filing | 2026-01-05 | English | ||
| 18269058 | 4 Filing | 2026-01-05 | English | ||
| 18269037 | 4 Filing | 2026-01-05 | English | ||
|
2025
8 filings
| |||||
| 18269100 | 10-K Filing | 2025-12-29 | English | ||
| 9417629 | PRIMARY DOCUMENT | 2025-12-05 | English | ||
| 9417630 | Regulatory Filings 2025 | 2025-12-04 | English | ||
| 9417631 | FORM 8-K | 2025-11-24 | English | ||
| 9417632 | FORM S-3 | 2025-11-07 | English | ||
| 9417635 | FORM 8-K | 2025-11-05 | English | ||
| 9417633 | PRIMARY DOCUMENT | 2025-10-02 | English | ||
| 9417634 | PRIMARY DOCUMENT | 2025-10-02 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CLARITY PHARMACEUTICALS LTD
Develops targeted copper-based radiopharmaceuticals for can…
|
CU6 | AU | Professional, scientific and te… |
|
CLEO DIAGNOSTICS LTD
Develops a blood-based diagnostic platform for early detect…
|
COV | AU | Professional, scientific and te… |
|
Climb Bio, Inc.
Clinical-stage biotech developing therapies for immune-medi…
|
CLYM | US | Professional, scientific and te… |
|
CO2 Solutions Inc.
Specializes in proprietary enzymatic processes for low-cost…
|
CST | CA | Professional, scientific and te… |
|
CODEXIS, INC.
A protein engineering company developing enzymes for therap…
|
CDXS | US | Professional, scientific and te… |
|
Cognetivity Neurosciences Ltd.
Medical tech company developing an AI platform for early de…
|
CGNSF | CA | Professional, scientific and te… |
|
COGNITION THERAPEUTICS INC
Clinical-stage company developing oral therapeutics for neu…
|
CGTX | US | Professional, scientific and te… |
|
COGSTATE LTD
Develops digital brain health assessments for clinical tria…
|
CGS | AU | Professional, scientific and te… |
|
Combigene AB
A gene therapy company focused on neurological disorders an…
|
COMBI | SE | Professional, scientific and te… |
|
Compugen Ltd.
A clinical-stage company developing cancer immunotherapies …
|
CGEN | IL | Professional, scientific and te… |
CEL SCI CORP via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34401/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34401 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34401 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34401 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34401}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CEL SCI CORP (id: 34401)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.